Skip to main content
MJH Life Sciences
  • Login
  • Register
  • Login
  • Register
Home
  • Topics
  • Dermatology
  • Cardiovascular
  • Diabetes
  • GI
  • HIV/AIDS
  • Photoclinic
  • Quiz
  • Special Report
  • Image IQ
MJH Life Sciences

SUBSCRIBE: eNewsletter

Cardiovascular Disease

SGLT2 Inhibitor Reduces CV, Renal Events in Type 2 Diabetes

June 17, 2019
  • Kenneth Bender, PharmD, MA

ADA 2019—Dapagliflozin reduced CV death, hospitalization for HF, and progression of CKD among T2DM patients with a wide distribution of baselines CVD risk in DECLARE-TIMI 58.

  • READ >>
Aspirin CVD prevention copyright Shane Maritch/Shutterstock.com

Aspirin for Primary CVD Prevention: Does this Patient Qualify?

June 12, 2019
  • Payal Kohli, MD

Daily aspirin for primary prevention of heart disease is a practice under scrutiny. Based on the new 2019 ACC/AHA CVD prevention guidelines, is this patient a candidate?

  • READ >>
reduce-it trial, reduce-it trial results, cardiology, cardiovascular disease CVD

REDUCE-IT Trial: A 5-question Quiz

May 30, 2019
  • Robert Derenbecker, MD
  • Seth Martin, MD, MHS

Test your knowledge of the key elements and outcomes of the highly buzzed about REDUCE-IT trial with this 5-question quiz.

  • VIEW NOW >>
cardiovascular disease prevention, cardiovascular disease risk factors, ASCVD

9 Questions on Primary CV Disease Prevention

May 2, 2019
  • Robert Derenbecker, MD
  • Seth Martin, MD, MHS

How much do you know about the 2019 ACC/AHA guidelines on the primary prevention of cardiovascular disease? Take this 9-question quiz to find out.

  • VIEW NOW >>

The Evolution of Exercise: 10 Main Events

May 1, 2019
  • Leo Robert

Man's need for exercise began with foraging for subsistence and is just as essential in our age of sitting and screen time. Trace the evolution, here.

  • VIEW NOW >>
Cardiovascular disease prevention, ASCVD, atheroscerlosis, heart disease

Primary Cardiovascular Prevention: 2019 ACC/AHA Guideline Update

April 17, 2019
  • Robert Derenbecker, MD
  • Seth Martin, MD, MHS

Eighty percent of all cardiovascular events are preventable. The ACC/AHA 2019 guidelines are a single source of best practices to help achieve that goal. Review them here, at-a-glance.

  • VIEW NOW >>
ACC.19, DECLARE-TIMI 58, REDUCE-IT

ACC.19: 3 Studies in Cardioprotection

March 25, 2019
  • Veronica Hackethal, MD

Dapagliflozin, icosapent ethyl, and bempedoic acid were found to reduce clinical or surrogate CV endpoints in studies presented at ACC.19, March 16-18, in New Orleans, LA.

  • VIEW NOW >>

Diabetes Drugs and Cardioprotection: 8 Questions on Key Trials

February 21, 2019
  • Grace Halsey

Find out what you know about which diabetes drugs in which classes show CV protective properties and results of the trials that support their use.

  • VIEW NOW >>

Quiz #3: AHA/ACC 2018 Lipid Guidelines

February 6, 2019
  • Aparna Sajja, MD
  • Seth Martin, MD, MHS

What approach is now AHA/ACC guideline-recommended for a patient with primary hypercholesterolemia, with an LDL-C of 192 mg/dL? Take Quiz #3.

  • VIEW NOW >>

AHA/ACC 2018 Guidelines on Treatment of Blood Cholesterol: Quiz #2

January 24, 2019
  • Aparna Sajja, MD
  • Seth Martin, MD, MHS

How will changes in the AHA/ACC update to the 2013 guidelines help optimize care for patients with ASCVD? Try part 2 of our 3-part quiz and find out.

  • VIEW NOW >>

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • next ›
  • last »

Resource Topics rightRail

  • Resource Topics
  • Partner Content
  • Cystic Fibrosis
  • Kidney Disease
  • Hepatitis C
  • Headache and Migraine
  • COPD Management
There is currently no available content. Please check back soon.
Connect with Us
  • Column 1
    • Home
    • About Us
    • Contact Us
  • Column 2
    • Editorial Info
    • Editorial Board
  • Column 3
    • Advertising Info
    • Reprints
    • Advertising Terms
  • Column 4
    • Terms of Use
    • Privacy Policy
Modern Medicine Network
© UBM 2019, All rights reserved.
Reproduction in whole or in part is prohibited.

We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".